Lab Research lands 5 new “top 35” pharma clients
Preclinical CRO Lab Research says new contracts are a sign of continuing recovery in market as well as firm’s ability to attract broader clientele base.
Preclinical CRO Lab Research says new contracts are a sign of continuing recovery in market as well as firm’s ability to attract broader clientele base.
Poland-based Selvita is providing drug discovery services to Rottapharm Madaus with the goal of creating a ser of designed and synthesised compounds.
The US FDA is set to make a final approval decision on the one remaining inhalable delivery insulin product, MannKind’s Afrezza, by December 29.
Pantec Biosolutions AG has secured a CHF20m ($19m) investment to further development of its needle-free in vitro fertilisation (IVF) therapy.
CROs MDCI and CDSS have partnered to expand their geographic reach and drive growth through cooperation.
Target Health and LifeOnKey have partnered to combine their eClinical and electronic health record (EHR) software.
Dow Wolff Cellulosics (DWC) and Colorcon say new excipient meets with growing demand for direct compression in tablet manufacturing.
Reaxa has received a UK Technology Strategy Board (TSB) award to further development of cleaner catalysts for pharmaceutical manufacturing.